Back to Search
ROBERT ROSATO, DMD
DMD
General Practice Dentistry
NPI: 1396902300Individual
Specialties, Licenses & Credentials
General Practice DentistryPrimary
Dentist — General Practice
Code: 1223G0001X
DS020038L(PA)
Research & Publications (20)
Appropriateness of early breast cancer management in relation to patient and hospital characteristics: a population based study in Northern Italy.
PMID 19051008·Breast Cancer Res Treat·2009
4-observational
Role of histone deacetylase inhibitor-induced reactive oxygen species and DNA damage in LAQ-824/fludarabine antileukemic interactions.
PMID 18852132·Mol Cancer Ther·2008
8-other
The multikinase inhibitor sorafenib potentiates TRAIL lethality in human leukemia cells in association with Mcl-1 and cFLIPL down-regulation.
PMID 17909059·Cancer Res·2007
8-other
Potentiation of the lethality of the histone deacetylase inhibitor LAQ824 by the cyclin-dependent kinase inhibitor roscovitine in human leukemia cells.
PMID 16275999·Mol Cancer Ther·2005
8-other
Histone deacetylase inhibitors: insights into mechanisms of lethality.
PMID 16083344·Expert Opin Ther Targets·2005
6-review
Evidence of a functional role for p21WAF1/CIP1 down-regulation in synergistic antileukemic interactions between the histone deacetylase inhibitor sodium butyrate and flavopiridol.
PMID 14978235·Mol Pharmacol·2004
8-other
Potent antileukemic interactions between flavopiridol and TRAIL/Apo2L involve flavopiridol-mediated XIAP downregulation.
PMID 15385934·Leukemia·2004
8-other
Histone deacetylase inhibitors in clinical development.
PMID 14680450·Expert Opin Investig Drugs·2004
6-review
The histone deacetylase inhibitor MS-275 promotes differentiation or apoptosis in human leukemia cells through a process regulated by generation of reactive oxygen species and induction of p21CIP1/WAF1 1.
PMID 12839953·Cancer Res·2003
8-other
Simultaneous activation of the intrinsic and extrinsic pathways by histone deacetylase (HDAC) inhibitors and tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) synergistically induces mitochondrial damage and apoptosis in human leukemia cells.
PMID 14707268·Mol Cancer Ther·2003
8-other
The cyclin-dependent kinase inhibitor flavopiridol disrupts sodium butyrate-induced p21WAF1/CIP1 expression and maturation while reciprocally potentiating apoptosis in human leukemia cells.
PMID 12467221·Mol Cancer Ther·2002
8-other
Evidence of a functional role for the cyclin-dependent kinase-inhibitor p21WAF1/CIP1/MDA6 in promoting differentiation and preventing mitochondrial dysfunction and apoptosis induced by sodium butyrate in human myelomonocytic leukemia cells (U937).
PMID 11408941·Int J Oncol·2001
8-other
The IGFBP-3 mRNA and protein levels are IGF-I-dependent and GH-independent in MG-63 human osteosarcoma cells.
PMID 11325513·Mol Cell Endocrinol·2001
8-other
Knowledge, practice and faith on Total Quality Management principles among workers in the Health Care System: evidence from an Italian investigation.
PMID 19239584·J Eval Clin Pract·2009
8-other
High-normal blood pressure is associated with a cluster of cardiovascular and metabolic risk factors: a population-based study.
PMID 19145777·J Hypertens·2009
8-other
Survival of pleural malignant mesothelioma in Italy: a population-based study.
PMID 18792097·Int J Cancer·2009
8-other
Survival of peritoneal malignant mesothelioma in Italy: a population-based study.
PMID 18792099·Int J Cancer·2009
8-other
What predicts the occurrence of the metabolic syndrome in a population-based cohort of adult healthy subjects?
PMID 19145586·Diabetes Metab Res Rev·2009
8-other
Personality profiles and subjective perception of pain in head pain patients.
PMID 19394764·Pain·2009
3-trial
Multidimensional geriatric assessment in treatment decision in elderly cancer patients: 6-year experience in an outpatient geriatric oncology service.
PMID 18723367·Crit Rev Oncol Hematol·2008
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 958 PERRY HWY
PITTSBURGH, PA 15237 - Phone
- (412) 364-5612
Quick Facts
- NPI
- 1396902300
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile